All clinical confidence ratings above apply to human outcomes, not animal findings
The Obesity Society (2025).
HMS: Writing review & editing, Methodology, Software, Writing original draft
In patients with type 2 diabetes, semaglutide reduces A1C by at least 1.0%
We wanted to make sure people had a sense of how we are perceiving this. In November, the Endocrine Society hosted a virtual science writers conference to discuss differences between FDA-approved medications for obesity and non-approved forms of these drugs
Sermorelin therapy is often used to support recovery, sleep quality, energy levels, and healthy aging through natural growth hormone stimulation